On a good day for the market, the Nasdaq has risen 0.5%, the S&P 500 has increased 0.6% and the Dow has moved up 0.5%. The healthcare sector is the category of stocks relating to medical and healthcare goods or services. This sector includes hospital management firms, health maintenance organizations (HMOs), biotechnology and a variety of medical products. Stocks in the healthcare sector are often considered to be defensive because the products and services are essential. Even during economic downturns, people will still require medical aid and medicine to overcome illness. Having a consistent demand for goods and services makes this sector less sensitive to business cycle fluctuations.
|Company||Market Cap||Percentage Change|
|VIVUS (Nasdaq:VVUS)||$1.15 billion||+9.8%|
|Ariad Pharmaceuticals (Nasdaq:ARIA)||$3.15 billion||+6%|
|Auxilium Pharmaceuticals (Nasdaq:AUXL)||$864.6 million||+4.8%|
|Pharmacyclics (Nasdaq:PCYC)||$4.25 billion||+3.3%|
|Genomic Health (Nasdaq:GHDX)||$833 million||+3.1%|
|NPS Pharmaceuticals (Nasdaq:NPSP)||$846.5 million||-2.8%|
|ISIS Pharmaceuticals (Nasdaq:ISIS)||$1.01 billion||-2.1%|
Broker Summary: TD Ameritrade Thinkorswim
VIVUS (Nasdaq:VVUS) is up 9.8% to reach a current price of $12.60 per share. So far today, the company's volume is 4.9 million shares.
Ariad Pharmaceuticals (Nasdaq:ARIA) has risen 6% and is currently trading at $20.07 per share. So far today, the company's volume is 5.2 million shares, 1.4 times its current daily average.
Auxilium Pharmaceuticals (Nasdaq:AUXL) has risen 4.8% to hit a current price of $18.41 per share. The company is currently trading a volume of 456,775 shares. This is one times its current three-month average.
Pharmacyclics (Nasdaq:PCYC) is at $63.08 per share after an increase of 3.3%. The company's volume is currently 166,944 shares for the day, lighter than yesterday's volume of 931,140 shares.
Rising 3.1%, Genomic Health (Nasdaq:GHDX) is currently trading at $27.92 per share. This morning, the company is trading a volume of 45,026 shares.
NPS Pharmaceuticals (Nasdaq:NPSP) is currently trading at a share price of $9.50, a 2.8% decline. At 337,035 shares, the company's volume so far today is 0.3 times the current daily average.
ISIS Pharmaceuticals (Nasdaq:ISIS) has decreased to $9.77 per share, a 2.1% fall. So far today, 558,234 shares have changed hands. This is 0.4 times the current three-month average.
The Bottom Line The nature of the market is such that stocks will have good days and bad days. It is important to weigh current activity against historical performance when making any investment decisions. Tools like valuation ratios and profit margins, however, are only as useful as the context you put them in; remember to take historical data and competitor performance into account.
Stock AnalysisThese three stocks are resilient, fundamentally sound and also pay generous dividends.
Investing NewsAre stocks cheap right now? Be wary of those who are telling you what you want to hear. Here's why.
Investing NewsHere are four stocks that offer good value and will likely outperform the majority of stocks throughout the broader market over the next several years.
Investing NewsHere are three resilient, dividend-paying companies that may mitigate some worry in an uncertain investing environment.
Stock AnalysisIf you're not sure where Ford and General Motors are going, you might want to look at this auto investment option instead.
Stock AnalysisLearn about the top energy companies in Russia, a country that holds some of the largest reserves of oil, natural gas and coal in the world.
Mutual Funds & ETFsExplore detailed analyses of the top buy-and-hold exchange traded funds, and learn about their characteristics, statistics and suitability.
Stock AnalysisLearn which Asian countries deliver the most crude oil to market, and discover what companies are the biggest producers in each country.
Stock AnalysisDiscover the top Russian oil companies by production volume and find out more about their domestic and international business operations.
Mutual Funds & ETFsLearn about arbitrage funds and how this type of investment generates profits by taking advantage of price differentials between the cash and futures markets.
When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>